Pulse pressure and inhibition of renin-angiotensin system in chronic kidney disease (original) (raw)
Renin angiotensin system blockade and cardiovascular outcomes in patients with chronic kidney disease and proteinuria: A meta-analysis
Lavanya Srinivasan
American Heart Journal, 2008
View PDFchevron_right
Progression of renal disease--can we forget about inhibition of the renin-angiotensin system? Authors' reply
Johannes Mann
Nephrology Dialysis Transplantation, 2006
View PDFchevron_right
Blood Pressure and Risk of All-Cause Mortality in Advanced Chronic Kidney Disease and Hemodialysis: The Chronic Renal Insufficiency Cohort Study
Akinlolu Ojo
Hypertension, 2014
View PDFchevron_right
Blood Pressure, Hypertension, RAAS Blockade, and Drug Therapy in Diabetic Kidney Disease
Hala Yamout, George Bakris
Advances in Chronic Kidney Disease, 2014
View PDFchevron_right
Renoprotective effect of renin-angiotensin-aldosterone system blockade in patients with predialysis advanced chronic kidney disease, hypertension, and anemia
Szu-Chun Hung
JAMA internal medicine, 2014
View PDFchevron_right
Renin–angiotensin system inhibition in advanced chronic kidney disease
arif Khwaja
Current Opinion in Nephrology & Hypertension, 2018
View PDFchevron_right
Retarding the progression of chronic kidney disease with renin angiotensin system blockade
Rajeev Annigeri
Indian Journal of Nephrology, 2012
View PDFchevron_right
RAAS Blockade as First-Line Antihypertensive Therapy among People with CKD
Pantelis Zebekakis
Renin-Angiotensin System - Past, Present and Future, 2017
View PDFchevron_right
DOPPS data suggest a possible survival benefit of renin angiotensin-aldosterone system inhibitors and other antihypertensive medications for hemodialysis patients
Friedrich Port
Kidney international, 2018
View PDFchevron_right
Systolic Blood Pressure and Outcomes in Stage 3–4 Chronic Kidney Disease Patients: Evidence from a Taiwanese Cohort
Jer Chia Tsai
American Journal of Hypertension, 2014
View PDFchevron_right
National Kidney Foundation consensus conference on cardiovascular and kidney diseases and diabetes risk: an integrated therapeutic approach to reduce events
George Bakris
Kidney International, 2010
View PDFchevron_right
Association of low blood pressure with increased mortality in patients with moderate to severe chronic kidney disease
Csaba Kovesdy
2006
View PDFchevron_right
The Combination of Beta Blockers and Renin-Angiotensin System Blockers Improves Survival in Incident Hemodialysis Patients: A Propensity-Matched Study
Rosa Ramos
Kidney International Reports, 2017
View PDFchevron_right
Management of Hypertension in Patients with Chronic Kidney Disease and Diabetes Mellitus
Hao-Min Cheng
The American Journal of Medicine, 2008
View PDFchevron_right
Late-onset renal failure from angiotensin blockade (LORFFAB) in 100 CKD patients
eileen samuel
2008
View PDFchevron_right
Global approach to cardiovascular risk in chronic kidney disease: Reality and opportunities for intervention
Giuseppe Conte
Kidney International, 2006
View PDFchevron_right
Treatment of hypertension in patients with nondiabetic chronic kidney disease
Marcel Ruzicka
Canadian Journal of Cardiology, 2007
View PDFchevron_right
Suboptimal blood pressure control in chronic kidney disease stage 3: baseline data from a cohort study in primary care
Richard Fluck
BMC Family Practice, 2013
View PDFchevron_right
Slowing chronic kidney disease progression: should we be looking beyond mean blood pressure?
Keith M Diaz
Hypertension Research, 2013
View PDFchevron_right
Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised controlled trial
Daniela Leonardis
The Lancet, 2005
View PDFchevron_right
Rationale—Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT): Evolving the management of cardiovascular risk in patients with chronic kidney disease
Ajay Singh
American Heart Journal, 2005
View PDFchevron_right
Effects of Renin-Angiotensin System Blockers on Renal Outcomes and All-cause Mortality in Patients With Diabetic Nephropathy: An Updated Meta-analysis
Panagiotis Stafylas
American Journal of Hypertension, 2008
View PDFchevron_right
Effect of Blood Pressure Lowering and Antihypertensive Drug Class on Progression of Hypertensive Kidney DiseaseResults From the AASK Trial
Jennifer Gassman
JAMA, 2002
View PDFchevron_right
Prescribing angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in chronic kidney disease (Review Article)
Paolo Ferrari
Nephrology, 2007
View PDFchevron_right
Guidelines at a crossroads Listening to the evidence - what trials on blood pressure targets in CKD say about current guidelines José Vinhas
jose vinhas
View PDFchevron_right
Role of Local Renin Angiotensin System Activation on Blood Pressure and Residual Renal Function in Peritoneal Dialysis Patients
ercan turkmen
Turkish Journal of Nephrology, 2019
View PDFchevron_right
Association of blood pressure with decline in renal function and time until the start of renal replacement therapy in pre-dialysis patients: a cohort study
Nora Voormolen, Diana Grootendorst
BMC Nephrology, 2011
View PDFchevron_right